Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Abbreviated MRI could become standard of care for prostate cancer diagnosis
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Late-stage prostate cancer diagnoses on the rise
Experts say these new findings highlight the need for more effective screening initiatives among men who may face access barriers.
Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer
When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision.
Shine working toward U.S. production of Mo-99 for SPECT imaging
Greg Piefer, PhD, chief executive and founder of SHINE, a Wisconsin-based radiopharmaceutical company that is building the world’s largest medical isotope production facility in Janesville, Wisconsin, explains progress on the company's fusion reactor that will become the first U.S. commercial supplier of molybdenum-99 in decades.
New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care
The method targets cancer stem cells, which are highly tumorigenic and known to play a significant role in relapse, cancer spread and treatment resistance.

Prostate cancer patients who undergo surveillance MRI in lieu of yearly biopsy not at increased risk

Results of the new work indicate that risks are not exacerbated when imaging is the chosen method of surveillance up until the three-year mark, suggesting that patients can safely forego invasive biopsy for a limited period.

Current LDCT eligibility criteria leave women and minorities behind

Compared to USPSTF 2013, modified eligibility criteria could increase cancer detection by 37%.

Radiomics-based models can detect pancreatic cancer well before clinical diagnosis

Recently a radiomics-based machine learning model proved highly accurate at predicting which patients would develop pancreatic cancer three to 36 months after abdominal CT imaging.

Disparities in breast cancer detection and care persist, despite a drop in mortality, new ACS report reveals

While Black women have lower incidence of breast cancer diagnosis, their mortality rates are 40% higher than those observed in white women.

New lesion measurement assesses treatment responses more accurately than RECIST

Researchers believe the new method of assessing treatment responses could pave the way for developing new cancer therapeutics.

New recommendations for cardiac CT in cardio-oncology imaging

The statement was written to fill gaps in recommendations from prior consensus statements and guidelines in regards to the use of CCT in cardio-oncology, including use of calcium scoring and ruling out coronary disease when cardiac function is impaired.

The approach—called GammaTile—involves placing small radiation seeds at a tumor site during surgery.

New radiation therapy treatment stalls recurrence while sparing healthy tissue in patients with brain cancer

The treatment has the potential to “extend lifespans and improve quality of life” in patients with brain cancer, according to experts at UC San Diego Health.

MRI/PSA combo cuts down on unnecessary biopsies in patients with suspected PCa

The strategy of combining the two tests improved specificity and positive predictive value in detecting clinically significant cancer compared to PSA alone.

Oncology Imaging

Abbreviated MRI could become standard of care for prostate cancer diagnosis

Late-stage prostate cancer diagnoses on the rise

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Shine working toward U.S. production of Mo-99 for SPECT imaging

New radioummonotherapy may be more effective at treating ovarian cancer than current standard of care